Back

Understanding BET inhibition as a novel pathway for cardiovascular risk modulation.

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: A novel approach for high CV risk patients with diabetes: the potential of epigenetics Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Jorge Plutzky

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction - A novel approach for high CV risk patients with diabetes: the potential of epigenetics.
Professor S. Del Prato (Pisa, IT)
Presentation thumbnail
The high risk diabetes patient with cardiovascular disease: what else can we target to reduce cardiovascular risk?
Professor K. Ray (London, GB)
Presentation thumbnail
BET inhibition in cardiovascular disease: a new dawn?
Professor J. Kastelein (Amsterdam, NL)
Presentation thumbnail
Discussion & summary - A novel approach for high CV risk patients with diabetes: the potential of epigenetics.
Professor S. Del Prato (Pisa, IT) Professor K. Ray (London, GB)

Access the full session

Session thumbnail
A novel approach for high CV risk patients with diabetes: the potential of epigenetics

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources